Sivgin, A. Et Al. 2013. The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload. 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) , (London, Canada).

Sivgin, A., Baldane, S., AKYOL, G., KEKLIK, M., KAYNAR, L., KURNAZ, F., ... PALA, Ç.(2013). The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload . 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Canada

Sivgin, A. Et Al. "The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload," 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Canada, 2013

Sivgin, A. Et Al. "The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload." 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) , London, Canada, 2013

Sivgin, A. Et Al. (2013) . "The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload." 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) , London, Canada.

@conferencepaper{conferencepaper, author={A. Sivgin Et Al. }, title={The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload}, congress name={39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)}, city={London}, country={Canada}, year={2013}}